TURNING POINT THERAPEUTICS I (TPTX)
US90041T1088 - Common Stock
Turning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational Updates
Positive feedback from pre-new drug application (NDA) meeting with U.S. Food and Drug Administration (FDA) focused on TRIDENT-1 registrational study of...
Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLC
Completed pre-NDA meeting to discuss proposed patient follow-up in ROS1+ advanced NSCLC with FDA...
The 3 Best Market Sectors for the Second Half of 2022
Compelling themes will drive a recovery in some sectors over the second half of 2022. The following are the best market sectors to buy into.
INVESTIGATION NOTICE: Halper Sadeh LLP Investigates TPTX, DRE, CVET, YMTX
/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
UnitedHealth, Shockwave Lead 5 Healthy Stocks Breaking Out Or Setting Up
Shockwave and UnitedHealth lead 5 stocks that are setting up or breaking out.
SHAREHOLDER ALERT: Weiss Law Reminds MBII, VMW, TPTX, and HMTV Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Turning Point Therapeutics and MD Anderson Announce Strategic Alliance to Advance Precision Cancer Therapies
HOUSTON and SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company...
Interesting TPTX Put Options For August 19th
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates TPTX, DRE, ELSE, PLD
/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds TPTX, PCSB, SREV, and HMTV Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
INVESTIGATION ALERT: Halper Sadeh LLP Investigates PCSB, TPTX, MUDS, CTT
/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds TPTX, PCSB, SREV, and HMTV Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
INVESTIGATION ALERT: Halper Sadeh LLP Investigates VMW, TPTX, CTT, CTEK
NEW YORK, NY / ACCESSWIRE / June 9, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Noteworthy Friday Option Activity: TPTX, AMLX, NCR
SHAREHOLDER ALERT: Weiss Law Investigates Turning Point Therapeutics, Inc.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Turning Point...
Turning Point Therapeutics shares more than doubled on Friday
Bristol-Myers says it will buy Turning Point Therapeutics for $4.10 billion. Turning Point Therapeutics shares jumped over 100% on Friday.
Friday Sector Leaders: Drugs, Biotechnology Stocks
CrowdStrike (CRWD) Stock Dips Despite Earnings Beat
CrowdStrike (CRWD) stock is falling on Friday despite a positive Q1 fiscal 2023 earnings report from the cybersecurity company.